Want to see MASS full AI Analyst Report?
MASS Stock Chart & Stats
$6.20
-$0.07(-3.29%)
At close: 4:00 PM EST
$6.20
-$0.07(-3.29%)
Day’s Range― - ―
52-Week Range$5.03 - $9.34
Previous CloseN/A
Volume74.64K
Average Volume (3M)284.90K
Market Cap
$328.98M
Enterprise Value$261.34M
Total Cash (Recent Filing)$111.74M
Total Debt (Recent Filing)$4.47M
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Aug 11, 2026EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.98
Shares Outstanding37,813,620
10 Day Avg. Volume271,371
30 Day Avg. Volume284,897
Financial Highlights & Ratios
PEG Ratio-0.08
Price to Book (P/B)1.32
Price to Sales (P/S)3.38
P/FCF Ratio-7.72
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue4.52
Enterprise Value/Gross Profit9.23
Enterprise Value/Ebitda-9.84
Forecast
1Y Price Target
$10.00Price Target Upside61.29% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.29
Revenue Forecast (FY)$65.94M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthA large cash balance with minimal leverage provides durable financial flexibility: it funds R&D, commercial expansion, and M&A integration without immediate financing, buying time to reach scaled profitability and supporting execution through 2–6 months of continued investment and potential shortfalls.
Installed Base Growth & Recurring RevenueConsistent device placements expanding the installed base increases addressable aftermarket spend for consumables, service and software. This structural shift toward subscription-like revenues supports more predictable cash flows and lifetime customer value as the base scales over months and years.
Margin Expansion And Profitability ProgressImproving adjusted gross margins and materially reduced adjusted EBITDA loss indicate better unit economics and operating discipline. If sustained, these fundamentals make a durable path to breakeven more likely by improving cash conversion as revenue scales and mix shifts toward higher-margin products.
Bears Say
Persistent Cash BurnChronic negative operating and free cash flow is a structural risk: continued cash consumption increases dependence on the current cash buffer and potential external financing. Unless operating cash generation flips sustainably, runway and optionality for growth investments will be constrained.
Ongoing Operating LossesDespite revenue scale-up, the company has not converted growth into sustained operating profitability. Persistent negative margins limit returns on invested capital and raise execution risk that scaling alone may not deliver durable positive cash flow within the medium term.
Recurring Revenue Pressure & Integration RiskA decline in consumables/service revenue and near-term acquisition (NIRLAB) drag create structural uncertainty in recurring revenue growth. Integration execution, U.S. market adoption and short-term profitability headwinds could delay the transition to a stable, subscription-weighted revenue base.
908 Devices News
MASS FAQ
What was 908 Devices Inc.’s price range in the past 12 months?
908 Devices Inc. lowest stock price was $5.03 and its highest was $9.34 in the past 12 months.
What is 908 Devices Inc.’s market cap?
908 Devices Inc.’s market cap is $328.98M.
When is 908 Devices Inc.’s upcoming earnings report date?
908 Devices Inc.’s upcoming earnings report date is Aug 11, 2026 which is in 40 days.
How were 908 Devices Inc.’s earnings last quarter?
908 Devices Inc. released its earnings results on May 06, 2026. The company reported -$0.082 earnings per share for the quarter, beating the consensus estimate of -$0.14 by $0.058.
Is 908 Devices Inc. overvalued?
According to Wall Street analysts 908 Devices Inc.’s price is currently Undervalued.
Does 908 Devices Inc. pay dividends?
908 Devices Inc. does not currently pay dividends.
What is 908 Devices Inc.’s EPS estimate?
908 Devices Inc.’s EPS estimate is -0.15.
How many shares outstanding does 908 Devices Inc. have?
908 Devices Inc. has 37,813,620 shares outstanding.
What happened to 908 Devices Inc.’s price movement after its last earnings report?
908 Devices Inc. reported an EPS of -$0.082 in its last earnings report, beating expectations of -$0.14. Following the earnings report the stock price went up 13.681%.
Which hedge fund is a major shareholder of 908 Devices Inc.?
Currently, no hedge funds are holding shares in MASS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
908 Devices Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$10.00 (61.29% Upside)
$10.00 (61.29% Upside)
Blogger Sentiment
Bullish
MASS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 132.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 7.6%
Last 30 Days ▼ 7.6%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.90%
12-Months-Change
Fundamentals
Return on Equity
-25.50%
Trailing 12-Months
Asset Growth
-4.76%
Trailing 12-Months
Company Description
908 Devices Inc.
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
MASS Company Deck
MASS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveys a predominantly positive operational and strategic trajectory: revenue and handheld product growth, improved margins, reduced adjusted EBITDA loss, strong cash position, and the strategic acquisition of NIRLAB that accelerates recurring revenue and expands addressable markets. Key near-term negatives include a wider GAAP net loss driven by a noncash contingent consideration revaluation, a decline in recurring revenue this quarter driven by service reductions, and a modest near-term EBITDA drag from NIRLAB as it is integrated and scaled in the U.S. On balance, the highlights (revenue growth, margin expansion, device momentum, strengthened guidance, cash balance, and accretive M&A strategy) significantly outweigh the lowlights, which are largely one-time accounting charges or manageable integration risks.View all MASS earnings summariesMASS Stock 12 Month Forecast
Average Price Target
$10.00
▲(61.29% Upside)
Technical Analysis
Senseonics Holdings
―
Quanterix
―
Nano-X Imaging
―
TriSalus Life Sciences
―
Cytek Biosciences
―
Ownership Overview
37.15% Insiders
10.61% Mutual Funds
16.10% Other Institutional Investors
23.88% Public Companies and
Individual Investors